Coadministration of Proton Pump Inhibitors and the Efficacy of Capecitabine in Patients With Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater

Cancer - United States
doi 10.1002/cncr.30553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Prevalance of Coadministration of Clopidogrel and Proton Pump Inhibitors

Journal of Health and Allied Sciences
2019English

Proton Pump Inhibitors Increase the Chemosensitivity of Patients With Advanced Colorectal Cancer

Oncotarget
Oncology
2017English

FLUCTUATING JAUNDICE IN THE ADENOCARCINOMA OF THE AMPULLA OF VATER: A Classic Sign or an Exception?

Arquivos de Gastroenterologia
Gastroenterology
2015English

Does the Treatment of Proton Pump Inhibitors Reduce Dysplasia or Adenocarcinoma Development in Barrett's Esophagus?

Turkish Journal of Gastroenterology
Gastroenterology
2017English

E0434 the Effects of Proton Pump Inhibitors on Clopidogrel Efficacy in Patients With ACS Through PCI in China

Heart
Cardiovascular MedicineCardiology
2010English

Adenocarcinoma of the Small Bowel

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2007English

Risks of Proton Pump Inhibitors for Patients With Cirrhosis: The Controversy Remains

Hepatology
MedicineHepatology
2017English

A Case of Gangliocytic Paraganglioma in the Ampulla of Vater

World Journal of Surgical Oncology
SurgeryOncology
2010English

Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells

Frontiers in Pharmacology
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy